Top Markets
#1 GEKKO GEKKO +52.86%
#2 ADO Protocol ADO Protocol +38.44%
#3 Pons Pons +31.32%
#4 Helium Helium +31.23%
#5 TENDIES TENDIES +22.79%
#6 龙虾 (Lobster) 龙虾 (Lobster) +20.33%
#7 o1.exchange o1.exchange +19.33%
#8 Giggle Fund Giggle Fund +18.75%
#9 Main Street Yield Main Street Yield +17.48%
#10 Cysic Cysic +15.13%
Coin of the day
GEKKO GEKKO
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Kedudukan dalam Saham #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Harga Saham
$12.94
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$1.10B
Perubahan (1 hari)
-0.16%
Perubahan (1 tahun)
-51.50%
Negara
US
Perdagangan Kolon TissueGene, Inc. (950160)

Kategori

Healthcare
Sejarah pecahan saham untuk Kolon TissueGene, Inc. (950160)
Saham Kolon TissueGene, Inc. (simbol: 950160) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 29, 2026.
Satu saham 950160 yang dibeli sebelum Aug 29, 2026 kini bersamaan dengan 0 saham 950160.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH